← Back to Search

Device

Intervention group for Pneumonia

N/A
Waitlist Available
Led By Francois Lellouche
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up hour0 to hour24 (1 day)
Awards & highlights

Study Summary

There is a high risk of transmission of COVID-19 to healthcare workers. In a recent cohort, 29% of the patients hospitalized were healthcare workers. Among the WHO's primary strategic objectives for the response to COVID-19, the first was to limit human-to-human transmission, including reducing secondary infections among close contacts and health care workers. Automated oxygen titration, weaning and monitoring (FreeO2 device) may be a solution to reduce the number of interventions of healthcare workers related to oxygen therapy, to reduce complications related to oxygen and to improve monitoring.

Eligible Conditions
  • Pneumonia
  • Coronavirus Infection
  • Oxygen Toxicity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~hour0 to hour24 (1 day)
This trial's timeline: 3 weeks for screening, Varies for treatment, and hour0 to hour24 (1 day) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Duration of interventions
The number of interventions
Secondary outcome measures
Cost-effectiveness
EWSO2 score evolution
Mean oxygen flow
+8 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment1 Intervention
Usual care will be provide to patients concerning their medical management. In the Intervention group, automated oxygen administration will be delivered with FreeO2
Group II: Control groupActive Control1 Intervention
Usual care will be provide to patients concerning their medical management. In the Control Group usual, oxygen will be delivered as per usual local practices

Find a Location

Who is running the clinical trial?

Laval UniversityLead Sponsor
417 Previous Clinical Trials
172,056 Total Patients Enrolled
2 Trials studying Pneumonia
90 Patients Enrolled for Pneumonia
Francois LellouchePrincipal InvestigatorIUCPQ-UL

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
The LancetJournal
Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study
Chen, Nanshan, Min Zhou, Xuan Dong, Jieming Qu, Fengyun Gong, Yang Han, Yang Qiu, et al.. 2020. “Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study”. The Lancet. Elsevier BV. doi:10.1016/s0140-6736(20)30211-7.
JamaJournal
Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus–infected Pneumonia in Wuhan, China
Wang, Dawei, Bo Hu, Chang Hu, Fangfang Zhu, Xing Liu, Jing Zhang, Binbin Wang, et al.. 2020. “Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus–infected Pneumonia in Wuhan, China”. Jama. American Medical Association (AMA). doi:10.1001/jama.2020.1585.
Value in HealthJournal
Good Research Practices for Cost-effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report
Ramsey, Scott, Richard Willke, Andrew Briggs, Ruth Brown, Martin Buxton, Anita Chawla, John Cook, et al.. 2005. “Good Research Practices for Cost-effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report”. Value in Health. Elsevier BV. doi:10.1111/j.1524-4733.2005.00045.x.
The LancetJournal
Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China
Huang, Chaolin, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, et al.. 2020. “Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China”. The Lancet. Elsevier BV. doi:10.1016/s0140-6736(20)30183-5.
All > Covid
~43 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top